1 |
PIP, "DRUG TARIFF PRICE INFORMATION,"
|
2 |
P. S. N. Committee, Professional Fees (Drug Tariff Part IIIA). 2022. https://psnc.org.uk/dispensing-supply/endorsement/fees-allowances/
|
3 |
D. K. Lee, "UK, Pharmacist prescriber status to be expanded," The Yakup, 2000. https://www.yakup.com/news/index.html?mode=view&nid=4945
|
4 |
E. Birbeck, "Clinical pharmacists supporting inpatient diabetes patients," Diabetes & Primary Care, Vol.21, No.5, 2019.
|
5 |
M. Ross, Pharmacist Tops Forbes' List of Best Health Care Jobs in 2015, Pharmacy Times, 2014. https://www.pharmacytimes.com/view/pharmacist-tops-em-forbes-em-list-of-best-health-care-jobs-in-2015.
|
6 |
C. Cheong and S. E. Choi, "Global trends in remuneration systems for community pharmacy services and implications to Korea," The Korean Journal of Health Economics and Policy, Vol.19, No.4, pp.129-151, 2013.
|
7 |
M. Matalavage, Navigating the Complexities of Pharmacy Reimbursement: Will We Ever Reach Transparency?, Pharmacy Times, 2016. https://www.pharmacytimes.com/view/navigating-the-complexities-of-pharmacy-reimbursement-will-we-ever-reach-transparency
|
8 |
S. M. Sarah Shoemaker-Hunt, Olivia Bacon, Jacqueline Gillis, Jason Brinkley, Marci Schalk, and Lauren Olsho, Cost of Dispensing Study, A. Associates, 2020.
|
9 |
W. H. Kim and E. Han, "A Review of the Efficiency of Pharmaceutical Expenditure in Korea," Public Finance Forum, Vol.290, pp.59-62, 2020. http://kiss.kstudy.com/thesis/thesis-view.asp?g=kissmeta&m=exp&enc=1A1EEE1DF2A2CA232BB7E
|
10 |
H. L. Kim, Y. H. Jo, J. H. Lee, E. Y. Jeon, J. Y. Lee, and E. M. Kim, "Research on the Relative Value of Pharmaceutical Care Services Performed by Hospital Pharmacists," [Research on the Relative Value of Pharmaceutical Care Services Performed by Hospital Pharmacists]. Journal of Korean Society of Health-System Pharmacists, Vol.38, No.2, pp.155-170, 2021. https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002719368 2021.
DOI
|
11 |
Y. Song, "Position and valuation of hospital pharmacy services within the fee-for-service system," Journal of Korean Society of Health-System Pharmacists, Vol.31, No.6, pp.1054-1066, 2014.
|
12 |
H. L. Kim, M. H. Kim and H. Park, "Comparative Study on Reimbursement Fees Related to Hospital Pharmacists'Services in Korea and Japan," Journal of Korean Society of Health-System Pharmacists, Vol.38, No.1, pp.75-92, 2021.
DOI
|
13 |
Y. H. Lee, J. N. Nam, and E. Cho, "The Factors Related to the Intention of Pharmacists for Participating in the Designated Pharmacy Program," Korean Journal of Community Pharmacy, Vol.3, No.2, pp.93-101, 2017.
|
14 |
W. Baqir, D. Miller, and G. Richardson, "A brief history of pharmacist prescribing in the UK," European Journal of Hospital Pharmacy: Science and Practice, Vol.19, No.5, pp.487-488, 2012.
DOI
|
15 |
M. Yearm, "The effect of the improvement of the sales regulation of general medicine and political proposals," Journal of channel and retailing, Vol.15, No.5, pp.237-255, 2010.
|
16 |
C. Wohlin, "Guidelines for snowballing in systematic literature studies and a replication in software engineering," Proceedings of the 18th international conference on evaluation and assessment in software engineering, 2014.
|
17 |
J. Kim, "A Study on the Health Insurance System in Japan : Comparison with Korea's Health Insurance," Ewha Women's University The Graduate School of Converging Clinical & Public Health, Master's Degree Thesis, 2019.
|
18 |
I. H. Lee, N. K. Je, E. J. Kyung, J. Y. Kim, and S. Lee, "Drug utilization review from a perspective of community pharmacists in South Korea: a qualitative study," The Korean Journal of Health Economics and Policy, Vol.17, No.3, pp.127-161. 2011.
|
19 |
B. K. Yoo, Y. S. Lee, and R. Y. Kang, "Current status of pharmaceutical care service in community pharmacy in Korea," Yaghag-hoi-ji, Vol.62, No.1, pp.14-20, 2018. https://doi.org/10.17480/psk.2018.62.1.142018.
DOI
|
20 |
B. Kim, "From Beveridge Welfare State to Cameron Government: A Case Study of Britain on the Role and Strategies of Think Tanks in Welfare State Paradigm Changes," Korean Journal of Social Welfare, Vol.67, No.2, pp.259-284. 2015.
DOI
|
21 |
J. Cylus, E. Richardson, L. Findley, M. Longley, C. O'Neill, D. Steel, and W. H. Organization, "United Kingdom: health system review," 2015.
|
22 |
A. M. Association, "CPT (Current Procedural Terminology)," Retrieved from https://www.ama-assn.org/amaone/cpt-current-proceduralterminology 2021.
|
23 |
S. H. Kim, M. H. Kim, E. H. Son, and H. Kim, "A Review on Service Fees of Pharmacists : Focused on the Medication Therapy Management Service in the United States," Journal of Korean Academy of Managed Care Pharmacy, Vol.7, No.2, pp.102-110, 2019.
|
24 |
G. B. Lee and H. Y. Kang, "Review of National Policies for Safe and Appropriate Use of Medications in Korea and Selected Countries," Journal of Korean academy of social & managed care pharmacy, Vol.5, No.1, pp.16-28, 2016,
|
25 |
K. E. Kwon, M. G. Kim, M. K. Shim, and H. Sohn, "The Status and Perception on Compounding Powdered Medicine for Adult Patients in Community Pharmacies," [The Status and Perception on Compounding Powdered Medicine for Adult Patients in Community Pharmacies]. Yakhak Hoeji, Vol.63, No.4, pp.185-191, 2019. https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002500320 2019.
DOI
|
26 |
K. Park, N. Kim, J. H. Kim, and S. Jang, "2019 The current health insurance systems and reformation trend in major countries," National Health Insurance Services, 8(United Kingdom). https://nl.go.kr/NL/contents/N20103000000.do?schM=contView&schOpt1=CA0000000031&schOpt2=CA0000000374&schOpt3=01&schIdSub=CO202011101402426521 2019, Services, N. H. "Primary care services," Retrieved from https://www.england.nhs.uk/get-involved/get-involved/how/primarycare/ 2022.
|
27 |
S. H. Kwon, E. H. Sohn, and H. L. Kim, "A Comparative Study on Health Insurance Fees Related to Community Pharmacists' Services in Korea and Japan," [A Comparative Study on Health Insurance Fees Related to Community Pharmacists' Services in Korea and Japan]. Yakhak Hoeji, Vol.65, No.1, pp.10-16, 2021. https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002690957
DOI
|
28 |
D. Chung, 2022 Dispensing Fee to rise by 3.6%, Korea Pharmaceutical Association News, 2021.
|
29 |
H. O. Lee and J. O. Byeon, "Capturing the Patient-centeredness and New Communities in the Perceived Roles of Community Pharmacists," Yakhak Hoeji, Vol.64, No.5, pp.418-429, 2020.
DOI
|
30 |
J. Yoon, "Development of a Pharmaceutical Care Service Model for Patients with Diabetes in Ambulatory Care Settings," Korean Journal of Clinical Pharmacy, Vol.27, No.1, pp.1-8, 2017.
DOI
|
31 |
Y. D. Park, [Contribution] Need to increase pharmacy service fee by reevaluation, Dailypharm, 2020. http://www.dailypharm.com/Users/News/NewsView.html?ID=270328
|
32 |
S. Y. Suha, et al., "Analysis of Work Activities and Proportion of Time Performed by Hospital Pharmacists," Journal of Korean Society of Health-System Pharmacists, Vol.37. No.2, pp.126-150, 2020.
DOI
|
33 |
S. Y. Nam, "The Study on Japanese Health Care Insurance and Medical Service Reimbursement System," Korean Medical Association, pp.1-346, 2010.
|
34 |
S. Lee, "Pharmacy retail system under the reformed pharmacy law," Korea Legislation Research Institute, 2009.
|
35 |
H. Eom, "The Revision of Medical Fee Schedule in Japan, 2020," HIRA Research, Vol.14, No.3, pp.66-76, 2020.
|
36 |
Y. S. Shin. H. J. Kang, D. K. Hwang, S. J. Kim, S. W. Kim, S. L. Ha, K. R. Park, J. H. Kim, E. W. Seo, Y. Ahn, J. H. Kim, H. S. Jung, H. S. Kim, J. I. Na, and S. J. Kim, Research on the finantial accountability for the 3rd reform of relative value scale, 2019.
|
37 |
Y. J. Kim, "NHS Hospital Pharmacist Training Programme in UK," Korean Journal of Clinical Pharmacy, Vol.25, No.4, pp.209-215, 2015.
|
38 |
C. Eickhoff, N. Griese-Mammen, U. Meller, A. Said, and M. Schulz, "Primary healthcare policy and vision for community pharmacy and pharmacists in Germany," Pharm Pract (Granada), Vol.19, No.1, 2248, 2021. https://doi.org/10.18549/PharmPract.2021.1.2248
DOI
|
39 |
G. Sachdev, M. A. Kliethermes, V. Vernon, S. Leal, and G. Crabtree, "Current status of prescriptive authority by pharmacists in the United States," Journal of the American College of Clinical Pharmacy, Vol.3, No.4, pp.807-817, 2020.
DOI
|
40 |
N. Agrawal, "Understanding Medicare Part B incident to billing," Bulletin of the American College of Surgeons, Vol.101, No.8, pp.51-52, 2016.
|
41 |
H. C. H. Karen Whalen, Reimbursement for pharmacist services, In Medication Therapy Management: A Comprehensive Approach (2e ed.). https://accesspharmacy.mhmedical.com/book.aspx?bookID=2319 2018.
|
42 |
D. Weitzman, Provider Status for Pharmacists: It's About Time, Pharmacy Times, 2020. https://www.pharmacytimes.com/view/provider-status-for-pharmacists-its-about-time
|
43 |
D. Oh, "A Study on the Sensitivity of Conversion Factor According to Change of Base Year," [A Study on the Sensitivity of Conversion Factor According to Change of Base Year]. Journal of the Korea Academy Industrial Cooperation Society, Vol.21, No.4, pp.201-209. 2020. https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002580068 2020.
|
44 |
J, H, Lee, H. S. Shin, and H. T. Shin, "Quality Evaluation of Medication Counseling in Korean Community Pharmacies," Korean Journal of Clinical Pharmacy, Vol.19, No.2, pp.131-145, 2009.
|
45 |
A. Cernasev, M. Aruru, S. Clark, K. Patel, N. Dipietro Mager, V. Subramaniam, andH. A. Truong, "Empowering Public Health Pharmacy Practice-Moving from Collaborative Practice Agreements to Provider Status in the U.S." Pharmacy, Vol.9, No.1, p.57, 2021. https://doi.org/10.3390/pharmacy90100572021.
DOI
|
46 |
Y. S. Shin, H. W Shin, D. K. Hwang, P. K. Yoon, and J. Na, "A research on the improvement of differential payment policy in primary care (dispensing)," In: Health Insurance Review and Assessment Service, 2009.
|